You are here » Media » Press releases

Press Releases

March 31, 2016
Restylane Now the World’s Broadest Hyaluronic Acid Filler Portfolio

Lausanne, Switzerland March 31st, 2016 - Galderma, the leading global dermatology company, today announced the further extension of the Restylane portfolio. With the integration of the Emervel range of Hyaluronic Acid fillers, new brand names and packaging, the company now offers the world’s broadest Hyaluronic Acid dermal filler portfolio. The new Restylane products will be launched world-wide in 2016, starting with the European markets in Q2.

Restylane is a range of Hyaluronic Acid (HA) dermal fillers for facial aesthetic treatments to reduce lines, folds and wrinkles, create fuller lips, enhance contours and facial volume, as well as improve skin quality, structure and elasticity.

The Restylane range now includes an additional five distinct textures: Restylane
Fynesse™, Restylane Refyne™, Restylane Defyne™, Restylane Volyme™ and Restylane Kysse™. This enables physicians to choose the right product to meet the specific needs of every patient under one trusted brand.

The expanded Restylane portfolio is even more versatile. We’ve made it easier for physicians to choose the right product with new packaging and product names. Now it is easier than ever for Health Care Practitioners (HCPs) to tailor every treatment to meet the individual needs of their patients”, says Anna Marsell, Director of Marketing, Galderma A&C. “HCPs who have limited experience with Restylane, now have every reason to explore the brand today”, adds Anna Marsell. 

In my opinion, the key to a successful treatment is a predictable, natural-looking result for each patient, tailored to meet their individual needs”, states Dr. Christoph Martschin, a European Dermatologist. He continues, “When you work with well-defined products, you are much more likely to achieve success. The strong reputation of safety and efficacy of the Restylane brand makes me confident that my patients will be satisfied when I treat them with these new products.”

Restylane was the world’s first stabilized non-animal HA filler brand. Over a 20-year
period, it has become one of the most trusted brands for natural-looking results. With
more than 28 million treatments performed and 20 years on the market, Restylane has a record of high patient satisfaction and safety. Restylane is proven to have high treatment longevity and efficacy that are supported by over 150 clinical studies on more than 3,000 subjects.

The new Restylane Portfolio now consists of nine products to meet different
patient needs:

  • Restoring a healthy, youthful appearance by filling lines and wrinkles or adding volume with Restylane, Restylane Refyne, Restylane Volyme and Restylane Fynesse
  • Enhancing facial balance and harmony by providing shape and contour with Restylane Lyft™, Restylane Defyne and Restylane Kysse
  • Refreshing the look for radiant and hydrated skin with Restylane Skinboosters™ Vital and Restylane Skinboosters™ Vital Light

About Galderma:
Dating back to 1961, Galderma is now present in over 100 countries with an extensive product portfolio to treat a range of dermatological conditions. The company partners with health care professionals around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin, hair and nails.

About Restylane:
Restylane is a range of Hyaluronic Acid (HA) dermal fillers for facial aesthetic treatments to efficiently reduce lines, folds and wrinkles, create fuller lips, enhance contours and facial volume, as well as improve skin quality, structure and elasticity. Restylane has an established safety profile based on over 2 decades of experience and extensive clinical documentation.
Today, with over 28 million treatments worldwide, Restylane is known for natural-looking results with long-lasting effects and high patient satisfaction.
The Restylane range is designed to complement the varying stages of facial aging for truly individualized treatments that suit all patient needs.

Within the Restylane range there are two main product ranges:

  • Restylane fillers, designed to enhance and restore facial features, from targeted superficial filling of wrinkles to deeper facial shaping and contouring
  • Restylane Skinboosters, a progressive approach to improved skin condition, designed to restore the skin’s hydrobalance and refresh the appearance

For additional information, please contact:
Mårten Forrest
Head of PR & Communication
Aesthetic & Corrective Business
Mobile: +46 768 98 1106
E-mail: marten.forrest@galderma.com

Posted in: Press release

Follow us Follow us on twitter Follow us on Linkedin

Corporate responsibility

Growing a responsible dermatological community

Discover some of the positive initiatives we are involved in across the world

Read

Video

We are committed

See all videos